Clinical Trials Browser

Phase 2 × Penile Neoplasms × enfortumab vedotin × Clear all

NCT06104618 2025-12-11

Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

Phase 2 Recruiting

Penile Neoplasms